1. Home
  2. Research and Development
  3. Collaboration

Research and Development


Working together with our partners we undertake the challenge of developing innovative new medicines.

RaQualia Pharma builds long-term relationships based on trust with our partners as we together implement technology cooperation agreements and joint research programs. Through these kinds of endeavors, we seek to make the drug discovery and development process faster and more efficient, which we hope will bring historic new medicines to the world more quickly. That is why we seek partners to undertake this challenge of developing new drugs with us.


Examples of Collaboration
  • Joint research and joint development
  • Commissioned research
  • Consulting agreements
  • Licensing of research tools (material transfer)
Examples of Partners
  • Universities
  • Public research institutions
  • Pharmaceutical companies
  • Bio-venture firms
  • Contract Research Organizations

Page Top

Corporate Information
CEO Message
Company Overview
Vision, Management Principle and Culture
Quality Policy
Corporate Governance
Business Model
Origins of Our Corporate Name and Logo
Press Release
Research & Development
Partnering in Research
What are Research Tools?
Research Tool Licensing
Product Information
Potassium-Competitive Acid Blocker
5-HT4 Partial Agonist
5-HT2B Antagonist
Motilin Receptor Agonist
Licensing Status
Shareholder and Investor Information
Vision, Management Principle and Culture
Corporate Governance
Outline of Securities Matters
IR Library
IR Calendar
IR Related News
Understanding RaQualia Pharma! RaQualia FAQ
RaQualia's History
What does RaQualia Pharma do?
How Does RaQualia Earn Revenues?
What About Dividends?
What are RaQualia's strengths?
What Does the Future Hold for RaQualia Pharma?
Contributions to Society
Corporate Contributions
Contributions to the Community
Press Release